Immune surveillance in multiple sclerosis patients treated with natalizumab

被引：0
|
作者：
Stuve, O
Marra, C
Jerome, KR
Cook, L
Cravens, PD
Cepok, S
Frohman, E
Phillips, T
Arendt, G
Hemmer, B
Monson, N
Racke, MK
机构：
来源：
NEUROLOGY | 2006年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [21] Cognitive evolution in Tysabri (natalizumab): treated multiple sclerosis patients
    Jacques, F.
    Harel, B. T.
    Schembri, A. J.
    Paquette, C.
    Gale, J.
    Bilodeau, B.
    JOURNAL OF NEUROLOGY, 2014, 261 : S306 - S306
  • [22] Cognitive evolution in Tysabri (natalizumab) treated multiple sclerosis patients
    Jacques, F.
    Harel, B. T.
    Schembri, A. J.
    Paquette, C.
    Gale, J.
    Bilodeau, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 461 - 461
  • [23] Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
    Carvajal, Rene
    Zabalza, Ana
    Carbonell-Mirabent, Pere
    Martinez-Gomez, Xavier
    Esperalba, Juliana
    Pappolla, Agustin
    Rando, Ariadna
    Cobo-Calvo, Alvaro
    Tur, Carmen
    Rodriguez, Marta
    Rio, Jordi
    Comabella, Manuel
    Castillo, Joaquin
    Rodrigo-Pendas, Jose angel
    Braga, Nathane
    Mongay-Ochoa, Neus
    Guio-Sanchez, Claudia
    Vidal-Jordana, Angela
    Arrambide, Georgina
    Rodriguez-Acevedo, Breogan
    Midaglia, Luciana
    Borras-Bermejo, Blanca
    Galan, Ingrid
    Sastre-Garriga, Jaume
    Montalban, Xavier
    Otero-Romero, Susana
    Tintore, Mar
    JAMA NETWORK OPEN, 2024, 7 (04) : E246345
  • [24] Trajectory of fatigue severity in natalizumab treated multiple sclerosis patients
    Yildiz, Murat
    Tettenborn, Barbara
    Borgwardt, Stefan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (07) : 902 - 903
  • [25] Delayed infusion reactions in multiple sclerosis patients treated with natalizumab
    Sangalli, F.
    Bucello, S.
    Moiola, L.
    Radaelli, M.
    Colombo, B.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S138 - S138
  • [26] Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
    Maier, Smaranda
    Simu, Mihaela
    Hutanu, Adina
    Barcutean, Laura
    Voidazan, Septimiu
    Bajko, Zoltan
    Motataianu, Anca
    Lata, Irina
    Balasa, Rodica
    BRAIN SCIENCES, 2020, 10 (11) : 1 - 11
  • [27] First natalizumab therapy survey on multiple sclerosis patients treated
    Pesci, I.
    Manneschi, L.
    Guareschi, A.
    Montanari, E.
    MULTIPLE SCLEROSIS, 2007, 13 : S167 - S167
  • [28] JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
    Major, Eugene O.
    Frohman, Elliot
    Douek, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2240 - 2241
  • [29] Formation of Anti-Natalizumab Antibodies in Natalizumab-Treated Multiple Sclerosis Patients
    Karlberg, Elin
    Lundkvist, Malin
    Jungedal, Roger
    Hillert, Jan
    Fogdell-Hahn, Anna
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 506 - 506
  • [30] Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases
    Eskazan, Ahmet Emre
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 680 - 681
12345